| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116705 NOVEL PDEs AND USES THEREOF |
| 05/24/2007 | US20070116703 Isolated mammalian membrane proteins; related agents |
| 05/24/2007 | US20070116694 Inhibitor of interaction of granzyme b with golgin-160 |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116691 Conditionally immortalized long-term stem cells and methods of making and using such cells |
| 05/24/2007 | US20070116690 Method for the generation of antigen-specific lymphocytes |
| 05/24/2007 | US20070116689 LIM mineralization protein splice variants |
| 05/24/2007 | US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116673 fusion proteins; membrane proteins; cancer, metastasis |
| 05/24/2007 | US20070116672 Treatment of rheumatic diseases |
| 05/24/2007 | US20070116670 providing a medicament for the therapy of YB-1 positive diseases, in particular of tumor diseases; expressing a gene or gene fragment in a tumor cell |
| 05/24/2007 | US20070116651 Starch binding domain as a tag for easier and less expensive purification of recombinant proteins using affinity matrix |
| 05/24/2007 | DE102006045391A1 Vorrichtung und Verfahren zur Nukleinsäure-Isolierung Apparatus and method for nucleic acid isolation |
| 05/24/2007 | DE102005054628A1 Verfahren zur Herstellung von permanenten humanen Zelllinien A process for the production of permanent human cell lines |
| 05/24/2007 | CA2630952A1 Multitargeting interfering rnas having two active strands and methods for their design and use |
| 05/24/2007 | CA2630932A1 Multitargeting interfering rnas and methods of their use and design |
| 05/24/2007 | CA2630559A1 Modified pore-forming protein toxins and use thereof |
| 05/24/2007 | CA2630409A1 Method and probes for identifying a nucleotide sequence |
| 05/24/2007 | CA2630349A1 Stabilizing formulations for recombinant viruses |
| 05/24/2007 | CA2630348A1 Inducible expression systems |
| 05/24/2007 | CA2630252A1 Influenza a virus detection method and kit therefor |
| 05/24/2007 | CA2630183A1 A method for in vitro molecular evolution of protein function |
| 05/24/2007 | CA2630173A1 Feedstuffs for aquaculture comprising stearidonic acid |
| 05/24/2007 | CA2630011A1 Skin repair accelerating therapeutic agent containing desacyl ghrelin and derivatives thereof as active ingredient |
| 05/24/2007 | CA2630006A1 Skin repair accelerating therapeutic agent containing ghrelin and derivatives thereof or substance acting on ghs-r1a as active ingredient |
| 05/24/2007 | CA2629786A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | CA2629715A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | CA2629521A1 Dof (dna binding with one finger) sequences and methods of use |
| 05/24/2007 | CA2629363A1 Emp4 gene |
| 05/24/2007 | CA2629350A1 Use of bacteriocins for promoting plant growth and disease resistance |
| 05/24/2007 | CA2629323A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 05/24/2007 | CA2629163A1 Adenoviral vector-based foot-and-mouth disease vaccine |
| 05/24/2007 | CA2628659A1 Combinations and methods of using an immunomodulatory oligodeoxynucleotide |
| 05/24/2007 | CA2627969A1 Identification of usa300 community-associated methicillin-resistant staphylococcus aureus |
| 05/24/2007 | CA2626092A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | CA2626084A1 Compositions and methods for altering alpha- and beta-tocotrienol content |
| 05/24/2007 | CA2625774A1 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 05/24/2007 | CA2567132A1 Process for the production of .delta.5-unsaturated fatty acids in transgenic organisms |
| 05/23/2007 | EP1788394A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins |
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788383A1 Dna sensor |
| 05/23/2007 | EP1788094A1 Method of distinguishing spinal cord neuron type targeting corl1 gene |
| 05/23/2007 | EP1788093A1 Instrument for detecting bacterium, method of detecting bacterium and kit for detecting bacterium |
| 05/23/2007 | EP1788090A1 Method for preparing artificial chromosomes which are free of host DNA |
| 05/23/2007 | EP1788089A1 Sequence of themotolerant l-rhamnose isomerase gene and use of the same |
| 05/23/2007 | EP1788088A1 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 05/23/2007 | EP1788087A1 Immunogenic detoxified mutant toxins |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1788084A1 Yeast promoter |
| 05/23/2007 | EP1788083A1 Method of assuming drug sensitivity to cdk4 inhibitor |
| 05/23/2007 | EP1788082A1 Nucleic acid construct |
| 05/23/2007 | EP1788080A1 Use of a thermostable phospholipase in the degumming of an oil or fat, and a method for obtaining a thermostable phopholipase |
| 05/23/2007 | EP1788075A1 Industrially useful microorganism |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787997A1 MU-1, member of the cytokine receptor family |
| 05/23/2007 | EP1787994A1 TB vaccine and diagnostic based on antigens from M. tuberculosis cell |
| 05/23/2007 | EP1787656A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 05/23/2007 | EP1787655A2 Meningococcal vaccine composition |
| 05/23/2007 | EP1787126A2 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 05/23/2007 | EP1786933A1 Methods and agents for screening for compounds capable of modulating gene expression |
| 05/23/2007 | EP1786925A2 Genes and polypeptides relating to breast cancers |
| 05/23/2007 | EP1786911A1 Cell lines for use in increasing protein yield from a cell culture |
| 05/23/2007 | EP1786910A2 Salt resistant transgenic plants |
| 05/23/2007 | EP1786909A1 Lipid metabolic and signalling pathways in the epidermis |
| 05/23/2007 | EP1786908A1 Plants with increased plastidic activity of r3 starch-phosphorylating enzyme |
| 05/23/2007 | EP1786907A2 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 05/23/2007 | EP1786906A2 Tumor specific genes and variant rnas and uses thereof as targets for cancer therapy and diagnosis |
| 05/23/2007 | EP1786905A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 05/23/2007 | EP1786904A2 Adenoviral vector compositions |
| 05/23/2007 | EP1786902A2 A novel class of therapeutic protein based molecules |
| 05/23/2007 | EP1786899A2 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid |
| 05/23/2007 | EP1786898A1 Crystal structure of haemophilus influenzae nad dependent dna ligase and uses thereof |
| 05/23/2007 | EP1786897A2 Means and methods for producing a stabilized cell of interest |
| 05/23/2007 | EP1786835A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 05/23/2007 | EP1786833A2 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 05/23/2007 | EP1786472A2 Antisense modulation of apolipoprotein b expression |
| 05/23/2007 | EP1786470A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 05/23/2007 | EP1786465A2 Methods for detecting and treating autoimmune disorders |
| 05/23/2007 | EP1786448A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 05/23/2007 | EP1786445A2 Live microbial microbicides |
| 05/23/2007 | EP1627049A4 Novel trichoderma genes |
| 05/23/2007 | EP1613752B1 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 05/23/2007 | EP1594446A4 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 05/23/2007 | EP1532516A4 Method for determining gene knockout strategies |
| 05/23/2007 | EP1519951B1 Cationic linear peptides having antifungal properties |
| 05/23/2007 | EP1432822B1 Method for recovering and analyzing a cellular component of cultured cells without having to harvest the cells first |
| 05/23/2007 | EP1370691B1 Method for detecting cytosine methylation patterns having high sensitivity |
| 05/23/2007 | EP1364205B1 Production of a monoclonal antibody by a transgenic avian |
| 05/23/2007 | EP1326993B1 Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system |
| 05/23/2007 | EP1326989B1 EXPRESSION VECTORS WITH MODIFIED ColE1 ORIGIN OF REPLICATION FOR CONTROL OF PLASMID COPY NUMBER |
| 05/23/2007 | EP1308512B1 Novel proteins and dnas thereof |
| 05/23/2007 | EP1307537B1 Neospora caninum isolate |
| 05/23/2007 | EP1244912B1 Methods for screening or evaluating the performance of a set of biological agents in living target cells and their uses |
| 05/23/2007 | EP1212619B1 Substrates and screening methods for transport proteins |
| 05/23/2007 | EP1210460B1 Gene cloning |